Science Explorer Back to mapMap
Institution · Zalgen (United States)

Most cited papers from Zalgen (United States)

What are the most cited papers from Zalgen (United States)?

The most cited paper from Zalgen (United States) is "The proximal origin of SARS-CoV-2" (Kristian G. Andersen, Andrew Rambaut, Walter Ian Lipkin et al., 2020), with 5,518 citations. Next come "Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone" (537) and "The origins of SARS-CoV-2: A critical review" (519).

Showing 50 of 60 papers. Every paper with more than 21 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The proximal origin of SARS-CoV-2 Kristian G. Andersen, Andrew Rambaut, Walter Ian Lipkin et al. · Nature Medicine Open access 17 Mar 2020 5,518
2 Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone John S. Schieffelin et al. · New England Journal of Medicine Open access 29 Oct 2014 537
3 The origins of SARS-CoV-2: A critical review Edward Charles Holmes et al. · Cell Open access 19 Aug 2021 519
4 The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic Michael Worobey, Joshua I. Levy, Lorena M. Malpica Serrano et al. · Science Open access 26 Jul 2022 457
5 Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus Kristian G. Andersen et al. · Cell Open access Aug 2015 330
6 The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Jonathan E. Pekar et al. · Science Open access 26 Jul 2022 258
7 Lassa Fever in Post-Conflict Sierra Leone Jeffrey G. Shaffer et al. · PLoS neglected tropical diseases Open access 20 Mar 2014 250
8 Structural basis for antibody-mediated neutralization of Lassa virus Kathryn M. Hastie, Michelle A. Zandonatti, Lara M. Kleinfelter et al. · Science Open access 2 Jun 2017 234
9 Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits James E. Robinson et al. · Nature Communications Open access 10 May 2016 185
10 Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time Kayla G. Barnes et al. · Nature Communications Open access 17 Aug 2020 184
11 Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever Chad E. Mire, Robert W. Cross, Joan B. Geisbert et al. · Nature Medicine Open access 4 Sep 2017 147
12 Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever Giovanni Lo Iacono, Andrew A. Cunningham, Élisabeth Fichet-Calvet et al. · PLoS neglected tropical diseases Open access 8 Jan 2015 130
13 Retinoic acid degradation shapes zonal development of vestibular organs and sensitivity to transient linear accelerations Kazuya Ono, James E. Keller, Omar López et al. · Nature Communications Open access 2 Jan 2020 105
14 Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades Raphaëlle Klitting et al. · Nature Communications Open access 27 Sep 2022 95
15 Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals Soumya Jaganathan, Francis Stieber, Sonia N. Rao et al. · Infectious Diseases and Therapy Open access 25 Aug 2021 81
16 Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies Robert W. Cross, Chad E. Mire, Luis M. Branco et al. · Antiviral Research Open access 15 Aug 2016 78
17 Analysis of CD8 + T cell response during the 2013–2016 Ebola epidemic in West Africa Saori Sakabe, Brian Martin Sullivan, Jessica N. Hartnett et al. · Proceedings of the National Academy of Sciences Open access 23 Jul 2018 68
18 Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice Vandana Kalia, Yevgeniy Yuzefpolskiy, Adithya Vegaraju et al. · Science Translational Medicine Open access 13 Oct 2021 67
19 Convergent Structures Illuminate Features for Germline Antibody Binding and Pan-Lassa Virus Neutralization Kathryn M. Hastie, Robert W. Cross, Stephanie S. Harkins et al. · Cell Open access Aug 2019 59
20 Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever Matthew L. Boisen et al. · Scientific Reports Open access 11 Apr 2018 56
21 Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection Robert W. Cross et al. · The Journal of Infectious Diseases Open access 31 Aug 2016 53
22 Emergence of an early SARS-CoV-2 epidemic in the United States Mark Zeller et al. · Cell Open access 27 Jul 2021 52
23 Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses Jacob C. Milligan et al. · Cell Open access Mar 2022 50
24 Antibody therapy for Lassa fever Robert W. Cross, Kathryn M. Hastie, Chad E. Mire et al. · Current Opinion in Virology ReviewOpen access Aug 2019 47
25 Ebola Virus Delta Peptide Is a Viroporin Jing He, Lilia I. Melnik, Alexander Komin et al. · Journal of Virology Open access 25 May 2017 44
26 Multiple Circulating Infections Can Mimic the Early Stages of Viral Hemorrhagic Fevers and Possible Human Exposure to Filoviruses in Sierra Leone Prior to the 2014 Outbreak Matthew L. Boisen et al. · Viral Immunology Open access 22 Dec 2014 44
27 Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodies Adrian S. Enriquez, Tierra K. Buck, Haoyang Li et al. · Cell Reports Open access May 2022 41
28 Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans Rodrigo Borrega et al. · Viruses Open access 21 Nov 2021 40
29 Multiplexing siRNAs to compress RNAi-based screen size in human cells Scott E. Martin, Tamara L. Jones, Cheryl L. Thomas et al. · Nucleic Acids Research Open access 29 Mar 2007 40
30 Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak Matthew L. Boisen et al. · Scientific Reports Open access 26 May 2020 39
31 High crossreactivity of human T cell responses between Lassa virus lineages Brian Martin Sullivan et al. · PLoS Pathogens Open access 6 Mar 2020 38
32 An Outbreak of Ebola Virus Disease in the Lassa Fever Zone Augustine Goba et al. · The Journal of Infectious Diseases Open access 11 Jul 2016 38
33 Epidemiology and Management of the 2013–16 West African Ebola Outbreak Matthew L. Boisen, Jessica N. Hartnett, Augustine Goba et al. · Annual Review of Virology ReviewOpen access 19 Aug 2016 38
34 Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali Nafomon Sogoba, Kyle Rosenke, Jennifer Adjemian et al. · Emerging infectious diseases Open access Mar 2016 38
35 Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection Matthew L. Boisen et al. · The Journal of Infectious Diseases Open access 11 Aug 2016 37
36 Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail Arnaud C. Drouin, Marc Theberge, Sharon Y. Liu et al. · Viruses Open access 23 Jun 2021 37
37 Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy Tereza Planck, Bushra Shahida, Hemang M. Parikh et al. · Thyroid 19 Aug 2014 37
38 A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus Robert W. Cross, Megan L. Heinrich, Karla A. Fenton et al. · Proceedings of the National Academy of Sciences Open access 17 Aug 2023 36
39 Development of Prototype Filovirus Recombinant Antigen Immunoassays Matthew L. Boisen et al. · The Journal of Infectious Diseases Open access 30 Jul 2015 36
40 The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens Kathryn M. Hastie, Lilia I. Melnik, Robert W. Cross et al. · The Journal of Infectious Diseases Open access 15 Oct 2023 34
41 Vectorborne Infections, Mali David Safronetz, Moussa Sacko, Nafomon Sogoba et al. · Emerging infectious diseases Open access 4 Jan 2016 34
42 Technical note: Bone DNA extraction and purification using silica‐coated paramagnetic beads Mary Jones Dukes, Audra L. Williams, Corina M. Massey et al. · American Journal of Physical Anthropology 28 Mar 2012 33
43 The evidence remains clear: SARS-CoV-2 emerged via the wildlife trade Robert F. Garry · Proceedings of the National Academy of Sciences Open access 10 Nov 2022 32
44 Programming of CD8 T Cell Quantity and Polyfunctionality by Direct IL-1 Signals Surojit Sarkar, Yevgeniy Yuzefpolskiy, Hanxi Xiao et al. · The Journal of Immunology 19 Nov 2018 32
45 PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial Scott Michael Norberg, Janet Valdez, Scott Napier et al. · The Lancet Respiratory Medicine Open access 21 Jan 2025 28
46 SARS-CoV-2 furin cleavage site was not engineered Robert F. Garry · Proceedings of the National Academy of Sciences Open access 29 Sep 2022 28
47 Neutralizing Antibodies against Lassa Virus Lineage I Tierra K. Buck, Adrian S. Enriquez, Sharon L. Schendel et al. · mBio Open access 22 Jun 2022 28
48 Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages Megan L. Heinrich et al. · Scientific Reports Open access 29 Sep 2020 28
49 The tumor microenvironment state associates with response to HPV therapeutic vaccination in patients with respiratory papillomatosis Scott Michael Norberg, Ke Bai, Cem M. Sievers et al. · Science Translational Medicine Open access 25 Oct 2023 27
50 Identification of Common CD8+T Cell Epitopes from Lassa Fever Survivors in Nigeria and Sierra Leone Saori Sakabe et al. · Journal of Virology Open access 6 Apr 2020 27

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.